UBS
-
Michael Klein’s attempted spin-off of Credit Suisse’s investment bank was complex and conflicted, but it could have reshaped the landscape in a way the UBS takeover does not -
The German cosmetics retailer fell over 7% below its IPO price on the first day of trading
-
The final size of the base deal will be Sfr2bn after the IPO was priced at the top of the range
-
Douglas is expected to achieve a multiple of 6.1-6.3 times its 2024 Ebitda
-
The biggest IPO of the year so far in Europe is multiple times covered, according to sources
-
US drug maker's stake in Haleon set to fall to 24%
-
Demand for domestic covered bonds drives strong outcomes for issuers
-
Europe's biggest IPO of the year so far gains traction with investors
-
Strong demand allows grid operator to tighten price and land inside fair value
-
French bank aims for size over price, but lands in line with euro funding sources
-
Over €12.5bn of orders pledged for rare and tightly priced covered bonds
-
Swiss bank expected to offer a pick-up over other non-eurozone names
